Profile data is unavailable for this security.
About the company
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
- Revenue in USD (TTM)0.00
- Net income in USD-26.25m
- Incorporated2017
- Employees58.00
- LocationBiomx Inc22 Einstein St., Floor 4NESS-ZIONA 7414003IsraelISR
- Phone+972 723942377
- Fax+1 8 002535177
- Websitehttps://www.biomx.com/
Mergers & acquisitions
Acquired company | PHGE:ASQ since announced | Transaction value |
---|---|---|
Adaptive Phage Therapeutics Inc | 313.04% | 2.11m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRX Pharmaceuticals Inc | 0.00 | -24.83m | 15.91m | 2.00 | -- | -- | -- | -- | -1.62 | -1.62 | 0.00 | -1.70 | 0.00 | -- | -- | -- | -197.97 | -120.57 | -- | -168.40 | -- | -- | -- | -- | -- | -189.12 | -- | -- | -- | -- | 24.14 | -- | -- | -- |
Cognition Therapeutics Inc | 0.00 | -31.08m | 16.05m | 25.00 | -- | 0.6973 | -- | -- | -0.9317 | -0.9317 | 0.00 | 0.5736 | 0.00 | -- | -- | 0.00 | -79.36 | -- | -104.49 | -- | -- | -- | -- | -- | -- | -263.29 | 0.00 | -- | -- | -- | -20.52 | -- | -- | -- |
Athira Pharma Inc | 0.00 | -113.45m | 16.25m | 65.00 | -- | 0.195 | -- | -- | -2.97 | -2.97 | 0.00 | 2.17 | 0.00 | -- | -- | 0.00 | -71.06 | -30.73 | -83.81 | -32.46 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.04 | -- | -- | -- |
Mira Pharmaceuticals Inc | 0.00 | -12.78m | 16.26m | 3.00 | -- | 7.33 | -- | -- | -0.8562 | -0.8562 | 0.00 | 0.1501 | 0.00 | -- | -- | 0.00 | -373.77 | -- | -737.47 | -- | -- | -- | -- | -- | -- | -3.17 | 0.00 | -- | -- | -- | -69.77 | -- | -- | -- |
OpGen Inc | 1.96m | -22.39m | 16.29m | 100.00 | -- | -- | -- | 8.29 | -20.01 | -20.01 | 1.66 | -8.65 | 0.1553 | -- | 6.09 | -- | -176.99 | -87.95 | -15,455.17 | -127.65 | 3.15 | 15.42 | -1,139.66 | -794.78 | -- | -20.25 | -- | -- | 31.11 | 3.02 | 12.38 | -- | 40.20 | -- |
Matinas BioPharma Holdings Inc | 0.00 | -22.91m | 16.50m | 32.00 | -- | 0.8639 | -- | -- | -5.10 | -5.10 | 0.00 | 3.81 | 0.00 | -- | -- | 0.00 | -78.48 | -44.62 | -85.80 | -48.25 | -- | -- | -- | -2,344.60 | -- | -- | 0.001 | -- | -65.62 | 55.71 | -9.26 | -- | -16.46 | -- |
AIM ImmunoTech Inc | 201.00k | -28.05m | 16.59m | 26.00 | -- | 2.45 | -- | 82.54 | -0.5703 | -0.5703 | 0.004 | 0.1068 | 0.0082 | -- | 12.18 | 7,730.77 | -113.70 | -45.64 | -149.16 | -48.35 | 71.14 | -231.75 | -13,952.74 | -11,695.01 | -- | -- | 0.3018 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
Microbot Medical Inc | 0.00 | -10.44m | 16.83m | 22.00 | -- | 2.69 | -- | -- | -0.81 | -0.81 | 0.00 | 0.3793 | 0.00 | -- | -- | 0.00 | -113.94 | -53.28 | -133.34 | -62.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.44 | -- | -31.76 | -- |
Geovax Labs Inc | 300.68k | -26.92m | 16.88m | 17.00 | -- | -- | -- | 56.14 | -13.05 | -13.05 | 0.1389 | -0.5526 | 0.0237 | -- | -- | 17,687.06 | -212.40 | -108.34 | -362.39 | -147.24 | -- | -- | -8,951.51 | -1,842.93 | -- | -- | -- | -- | -100.00 | -- | -85.20 | -- | -- | -- |
Biomx Inc | 0.00 | -26.25m | 17.00m | 58.00 | -- | -- | -- | -- | -0.4575 | -0.4575 | 0.00 | 0.3929 | 0.00 | -- | -- | 0.00 | -47.79 | -- | -57.76 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.59 | -- | -- | -- |
Palatin Technologies, Inc. | 4.49m | -29.74m | 17.02m | 30.00 | -- | -- | -- | 3.79 | -1.97 | -1.97 | 0.2981 | -0.0062 | 0.3131 | 0.3713 | 3.08 | 149,669.70 | -207.35 | -55.28 | -1,527.99 | -69.08 | 97.83 | -- | -662.26 | -1,359.14 | 1.01 | -- | -- | -- | -7.49 | -40.52 | -23.71 | -- | 3.31 | -- |
Impact Biomedical Inc | 0.00 | -4.25m | 17.25m | 1.00 | -- | 0.7399 | -- | -- | -0.3694 | -0.3694 | 0.00 | 2.03 | 0.00 | -- | -- | 0.00 | -9.59 | -- | -15.04 | -- | -- | -- | -- | -- | -- | -5.12 | 0.3377 | -- | -100.00 | -- | 38.51 | -- | -- | -- |
Synlogic Inc | 3.17m | -56.16m | 17.54m | 6.00 | -- | 1.10 | -- | 5.53 | -7.24 | -7.24 | 0.3549 | 1.37 | 0.0628 | -- | -- | 528,333.30 | -111.31 | -40.57 | -131.17 | -43.82 | -- | -- | -1,771.74 | -3,245.93 | -- | -- | 0.00 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
Bioxytran Inc | 0.00 | -3.51m | 17.80m | 2.00 | -- | -- | -- | -- | -0.023 | -0.023 | 0.00 | -0.0023 | 0.00 | -- | -- | -- | -2,635.88 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -20.68 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
MEI Pharma Inc | 65.30m | 17.78m | 18.06m | 28.00 | 1.02 | 0.5468 | 0.9942 | 0.2765 | 2.67 | 2.67 | 9.80 | 4.96 | 0.8052 | -- | 1,536.40 | 2,332,036.00 | 21.92 | -21.09 | 26.64 | -23.99 | -- | -- | 27.23 | -72.23 | -- | -- | 0.00 | -- | 33.76 | 67.75 | 155.84 | -- | -49.68 | -- |
Cocrystal Pharma Inc | 0.00 | -17.93m | 18.11m | 12.00 | -- | 1.04 | -- | -- | -1.76 | -1.76 | 0.00 | 1.71 | 0.00 | -- | -- | 0.00 | -61.98 | -50.94 | -66.88 | -52.77 | -- | -- | -- | -1,501.78 | -- | -- | 0.00 | -- | -- | -- | 53.69 | -- | 33.34 | -- |
Holder | Shares | % Held |
---|---|---|
Renaissance Technologies LLCas of 30 Jun 2024 | 22.80k | 0.03% |
Millennium Management LLCas of 31 Mar 2024 | 19.76k | 0.03% |
Jump Trading LLCas of 31 Mar 2024 | 19.21k | 0.03% |
XTX Markets LLCas of 31 Mar 2024 | 10.19k | 0.02% |
Raymond James Financial Services Advisors, Inc.as of 30 Jun 2024 | 10.00k | 0.01% |
PNC Bank, NA (Investment Management)as of 30 Jun 2024 | 4.00k | 0.01% |
Bank of America, NA (Private Banking)as of 31 Mar 2024 | 1.00 | 0.00% |
MM Asset Management, Inc.as of 31 Mar 2024 | 0.00 | 0.00% |
G1 Execution Services LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Walleye Capital LLCas of 31 Mar 2024 | 0.00 | 0.00% |